Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?
Human papillomaviruses (HPV) are detected in 70–80% of oropharyngeal cancers in the developed world, the incidence of which has reached epidemic proportions. The current paradigm regarding the status of the viral genome in these cancers is that there are three situations: one where the viral genome...
Main Authors: | Iain M. Morgan, Laurence J. DiNardo, Brad Windle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/9/8/208 |
Similar Items
-
Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma
by: Katherine C. Wai, et al.
Published: (2020-02-01) -
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells
by: H Barzegar, et al.
Published: (2017-11-01) -
Prevalence of High risk Human Papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan
by: Sana Gul, et al.
Published: (2015-05-01) -
PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS
by: Michał Wiciński, Kamil Leis, et al.
Published: (2018-06-01) -
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study
by: Hamšíková Eva, et al.
Published: (2011-07-01)